Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Mirzotamab (Anti-B7-H3 / CD276) For research use only.
Not for use in humans.

Mirzotamab (Anti-B7-H3 / CD276)

Synonyms:

Mirzotamab (Anti-B7-H3 / CD276) is a human IgG1κ monoclonal antibody targeting CD276/B7-H3. Mirzotamab is used to produce Mirzotamab clezutoclax antibody drug conjugate (ADC). MW: 144.86 KD.

Mirzotamab (Anti-B7-H3 / CD276)

Purity & Quality Control

Batch: A293501 Purity: 99% Protein concentration: 10.06mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Mirzotamab (Anti-B7-H3 / CD276) is a human IgG1κ monoclonal antibody targeting CD276/B7-H3. Mirzotamab is used to produce Mirzotamab clezutoclax antibody drug conjugate (ADC). MW: 144.86 KD.

Product Details

CAS No. 2229859-11-2
Molecular Weight 144.86
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mirzotamab (Anti-B7-H3 / CD276) | Mirzotamab (Anti-B7-H3 / CD276) supplier | purchase Mirzotamab (Anti-B7-H3 / CD276) | Mirzotamab (Anti-B7-H3 / CD276) cost | Mirzotamab (Anti-B7-H3 / CD276) manufacturer | order Mirzotamab (Anti-B7-H3 / CD276) | Mirzotamab (Anti-B7-H3 / CD276) distributor